#	Title	Focus Area	Year	Dose
1	Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects	Insulin	2023	250mg
2	Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial	Arteries	2023	250mg
3	Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study	Obesity	2023	2,000mg
4	The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial	Safety Efficacy	2022	300mg 600mg 900mg
5	Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study	Diabetes	2022	250mg
6	Nicotinamide Mononucleotide Is Safely Metabolized and Significantly Reduces Blood Triglyceride Levels in Healthy Individuals	Blood Triglycerides	2022	300mg
7	Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women	Safety	2022	1,250mg
8	Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial	Metabolism Arteries	2022	250mg
9	Clinical evaluation of changes in biomarkers by oral intake of NMN	Biomarkers Efficacy	2022	300mg
10	Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men	Muscle Function Men	2022	250mg
11	A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults	Safety Efficacy	2022	300mg
12	Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women	Insulin Women	2022	250mg
13	Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects	Safety Efficacy	2022	250mg
14	Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study	Sleep Quality Fatigue	2022	250mg
15	MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults	Efficacy	2022	1,000mg
16	Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study	Aerobic Capacity	2021	1,200mg
17	Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men	Efficacy	2020	500mg

• Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota

• Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence

• Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis

• The therapeutic potential of resveratrol: a review of clinical trials

• Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review

• Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities

• The role of resveratrol in neurogenesis: a systematic review

• Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota

• Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
  

• The Beneficial Role of Apigenin against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations 

• Experimental evidence for anti-metastatic actions of apigenin: a mini review

• Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models

• Apigenin-Loaded Stealth Liposomes: Development and Pharmacokinetic Studies for Enhanced Plasma Retention of Drug in Cancer Therapy

• The Beneficial Role of Apigenin against Cognitive and Neurobehavioural Dysfunction: A Systematic Review of Preclinical Investigations 

• The Therapeutic Potential of Apigenin

• Apigenin and its dermatological applications: A comprehensive review

• Apigenin: a natural molecule at the intersection of sleep and aging

• The Effects of Apigenin in the Treatment of Diabetic Nephropathy: A Systematic Review of Non-clinical Studies

• Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications

• Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial

• The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review

• Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

• Therapeutic Application of Berberine: a Consolidated Review

• Berberine in the Treatment of Diabetes Mellitus: A Review

• The effect of Berberine on weight loss in order to prevent obesity: A systematic review

• Berberine: metabolic and cardiovascular effects in preclinical and clinical trials

• The Effects of Berberine on Blood Lipids:
  A Systemic Review and Meta-Analysis of
  Randomized Controlled Trials

• Therapeutic Application of Berberine: a Consolidated Review